Suppr超能文献

评估载有地匹福林的聚合物纳米粒的物理化学性质和稳定性。

Assessing the physical-chemical properties and stability of dapivirine-loaded polymeric nanoparticles.

机构信息

CICS - Centro de Investigação em Ciências da Saúde, Department of Pharmaceutical Sciences, Instituto Superior de Ciências da Saúde-Norte, CESPU, Rua Central de Gandra 1317, 4585-116 Gandra, Portugal; Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.

出版信息

Int J Pharm. 2013 Nov 18;456(2):307-14. doi: 10.1016/j.ijpharm.2013.08.049. Epub 2013 Sep 4.

Abstract

Nanocarriers may provide interesting delivery platforms for microbicide drugs and their characterization should be addressed early in development. Differently surface-engineered dapivirine-loaded, poly(epsilon-caprolactone) (PCL)-based nanoparticles (NPs) were obtained by nanoprecipitation using polyethylene oxide (PEO), sodium lauryl sulfate (SLS), or cetyltrimethylammonium bromide (CTAB) as surface modifiers. Physical-chemical properties of NP aqueous dispersions were evaluated upon storage at -20-40 °C for one year. NPs presented 170-200 nm in diameter, roundish-shape, low polydispersity index (≤0.18), and high drug association efficiency (≥97%) and loading (≥12.7%). NPs differed in zeta potential, depending on surface modifier (PEO: -27.9 mV; SLS: -54.7 mV; CTAB: +42.4 mV). No interactions among formulation components were detected by differential scanning calorimetry (DSC) and Fourier transform infrared spectroscopy (FTIR), except for SLS-PCL NPs. Colloidal properties of NPs were lost at -20 °C storage. Negatively charged NPs were stable up to one year at 5-40°C; as for CTAB-PCL NPs, particle aggregation was observed from 30 to 90 days of storage depending on temperature. Colloidal instability affected the in vitro drug release of CTAB-PCL NPs after 360 days. In any case, no degradation of dapivirine was apparent. Overall, PEO-PCL and SLS-PCL NPs presented suitable properties as nanocarriers for dapivirine. Conversely, CTAB-PCL NPs require additional strategies in order to increase stability.

摘要

纳米载体可为杀微生物剂药物提供有吸引力的递药平台,因此应在研发早期对其进行表征。通过使用聚环氧乙烷(PEO)、十二烷基硫酸钠(SLS)或十六烷基三甲基溴化铵(CTAB)作为表面改性剂,通过纳米沉淀法制备了不同表面修饰的载双夫定、聚己内酯(PCL)纳米颗粒(NPs)。在-20-40°C 下储存 1 年后,评估了 NP 水分散体的物理化学性质。NP 呈圆形,粒径为 170-200nm,具有低多分散指数(≤0.18)、高药物结合效率(≥97%)和载药量(≥12.7%)。根据表面改性剂的不同,NP 的 zeta 电位也有所不同(PEO:-27.9 mV;SLS:-54.7 mV;CTAB:+42.4 mV)。差示扫描量热法(DSC)和傅里叶变换红外光谱(FTIR)未检测到制剂成分之间存在相互作用,除了 SLS-PCL NPs。在-20°C 储存时,NP 的胶体性质丧失。带负电荷的 NPs 在 5-40°C 下可稳定保存 1 年;对于 CTAB-PCL NPs,取决于温度,在储存 30-90 天内观察到颗粒聚集。胶体不稳定性影响 CTAB-PCL NPs 在 360 天后的体外药物释放。无论如何,均未明显观察到双夫定的降解。总体而言,PEO-PCL 和 SLS-PCL NPs 作为双夫定的纳米载体具有合适的性质。相反,CTAB-PCL NPs 需要额外的策略来提高稳定性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验